Page last updated: 2024-08-23

lithium and Depressive Disorder, Major

lithium has been researched along with Depressive Disorder, Major in 110 studies

Research

Studies (110)

TimeframeStudies, this research(%)All Research%
pre-199016 (14.55)18.7374
1990's2 (1.82)18.2507
2000's29 (26.36)29.6817
2010's40 (36.36)24.3611
2020's23 (20.91)2.80

Authors

AuthorsStudies
Adli, M; Bopp, SK; Buspavanich, PJ; Heilbronner, U; Heinz, A; Lang, UE; Mühleisen, TW; Ricken, R; Schlattmann, P; Schulze, TG1
Ahearn, E; Boney, TY; Conrad, CH; DeLisi, LE; Doros, G; Ferguson, R; Hoffman, B; Holmberg, EF; Huang, GD; Katz, IR; Kaufman, JS; Lew, R; Liang, MH; Ostacher, MJ; Paik, JM; Ringer, RJ; Rogers, MP; Smith, EG; Thwin, SS1
Adl, M; Akiyama, K; Akula, N; Alda, M; Amare, AT; Ardau, R; Arias, B; Aubry, JM; Backlund, L; Bauer, M; Baune, BT; Bellivier, F; Benabarre, A; Bengesser, S; Bhattacharjee, AK; Biernacka, JM; Birner, A; Cearns, M; Cervantes, P; Chen, HC; Chillotti, C; Cichon, S; Clark, SR; Colom, F; Cruceanu, C; Czerski, PM; Dalkner, N; Dayer, A; Degenhardt, F; Del Zompo, M; DePaulo, JR; Étain, B; Falkai, P; Ferensztajn-Rochowiak, E; Forstner, AJ; Frank, J; Frisen, L; Frye, MA; Fullerton, JM; Gard, S; Garnham, JS; Goes, FS; Grigoroiu-Serbanescu, M; Grof, P; Hashimoto, R; Hauser, J; Heilbronner, U; Herms, S; Hoffmann, P; Hou, L; Hsu, YH; Jamain, S; Jiménez, E; Kahn, JP; Kassem, L; Kato, T; Kelsoe, J; Kittel-Schneider, S; König, B; Kuo, PH; Kusumi, I; Laje, G; Landén, M; Lavebratt, C; Leboyer, M; Leckband, SG; Maj, M; Manchia, M; Marie-Claire, C; Martinsson, L; McCarthy, MJ; McElroy, S; McMahon, FJ; Mitchell, PB; Mitjans, M; Mondimore, FM; Monteleone, P; Nievergelt, CM; Nöthen, MM; Novák, T; O'Donovan, C; Ösby, U; Ozaki, N; Papiol, S; Pfennig, A; Pisanu, C; Potash, JB; Reif, A; Reininghaus, E; Rietschel, M; Roberts, G; Rouleau, GA; Rybakowski, JK; Schalling, M; Schofield, PR; Schubert, KO; Schulze, TG; Schweizer, BW; Severino, G; Shekhtman, T; Shilling, PD; Shimoda, K; Simhandl, C; Slaney, CM; Squassina, A; Stamm, T; Stopkova, P; Streit, F; Tekola-Ayele, F; Thalamuthu, A; Tortorella, A; Turecki, G; Veeh, J; Vieta, E; Witt, SH; Zandi, PP1
Honyashiki, M; Inoue, T; Terao, I1
Adli, M; Akiyama, K; Akula, N; Alda, M; Amare, AT; Ardau, R; Arias, B; Aubry, J; Backlund, L; Bauer, M; Baune, BT; Bellivier, F; Benabarre, A; Bengesser, S; Bhattacharjee, AK; Biernacka, JM; Birner, A; Brichant-Petitjean, C; Cearns, M; Cervantes, P; Chen, H; Chillotti, C; Cichon, S; Clark, SR; Colom, F; Cruceanu, C; Czerski, PM; Dalkner, N; Dayer, A; Degenhardt, F; DePaulo, JR; Étain, B; Falkai, P; Forstner, AJ; Frank, J; Frisen, L; Frye, MA; Fullerton, JM; Gard, S; Garnham, JS; Goes, FS; Grigoroiu-Serbanescu, M; Grof, P; Hashimoto, R; Hauser, J; Heilbronner, U; Herms, S; Hoffmann, P; Hofmann, A; Hou, L; Hsu, YH; Jamain, S; Jiménez, E; Kahn, JP; Kassem, L; Kato, T; Kelsoe, J; Kittel-Schneider, S; Kliwicki, S; König, B; Kuo, PH; Kusumi, I; Laje, G; Landén, M; Lavebratt, C; Leboyer, M; Leckband, SG; Maj, M; Manchia, M; Martinsson, L; McCarthy, MJ; McElroy, S; McMahon, FJ; Millischer, V; Mitchell, PB; Mitjans, M; Mondimore, FM; Monteleone, P; Nievergelt, CM; Nöthen, MM; Novák, T; O'Donovan, C; Ozaki, N; Papiol, S; Pfennig, A; Pisanu, C; Potash, JB; Reif, A; Reininghaus, E; Rietschel, M; Roberts, G; Rouleau, GA; Rybakowski, JK; Schalling, M; Schofield, PR; Schubert, KO; Schulze, TG; Schweizer, BW; Severino, G; Shekhtman, T; Shilling, PD; Shimoda, K; Simhandl, C; Slaney, CM; Squassina, A; Stamm, T; Stopkova, P; Streit, F; TekolaAyele, F; Thalamuthu, A; Tortorella, A; Turecki, G; Veeh, J; Vieta, E; Witt, SH; Zandi, PP; Zompo, MD1
Gao, TH; Li, T; Ma, XH; Ni, PY; Ni, RJ; Tian, Y; Wang, YY; Wei, JX; Zhao, LS1
Caldieraro, MA; Feiten, JG; Géa, LP; Kauer-Sant'Anna, M; Salum, GA; Scotton, E; Silveira Júnior, ÉM; Valiati, FE1
Davis, RE; Dutheil, S; Snyder, GL; Watson, LS1
Chen, R; Davis, RE; Durgam, S; Kozauer, SG; Lakkis, HD; Mates, S; McIntyre, RS; Satlin, A; Suppes, T; Tohen, M; Vanover, KE1
Ercis, M; Ozerdem, A; Singh, B1
Ferguson, R; Hernán, MA; Katz, IR; Lew, R; Liang, MH; Madenci, A; Szmulewicz, A1
Bachu, A; Madangarli, N; Patel, RS; Youssef, NA1
Andersson, P; Desai Boström, AE; Jarbin, H; Jokinen, J; Lundberg, J1
Baldessarini, RJ; Berardelli, I; Erbuto, D; Germano, L; Pompili, M; Rogante, E; Sarli, G; Sarubbi, S1
Andersson, E; Boberg, J; Clements, CC; Jonsson, L; Karlsson, R; Kowalec, K; Landén, M; Lewis, CM; Lu, Y; Rück, C; Sigström, R; Song, J; Sullivan, PF; Xiong, Y1
Kirsch, I1
Adli, M; Akiyama, K; Akula, N; Alda, M; Amare, AT; Ardau, R; Arias, B; Aubry, JM; Backlund, L; Bauer, M; Baune, BT; Bellivier, F; Benabarre, A; Bengesser, S; Bhattacharjee, AK; Biernacka, JM; Birner, A; Brichant-Petitjean, C; Cearns, M; Cervantes, P; Chen, HC; Chillotti, C; Cichon, S; Clark, SR; Colom, F; Cruceanu, C; Czerski, PM; Dalkner, N; Dayer, A; Degenhardt, F; Del Zompo, M; DePaulo, JR; Étain, B; Falkai, P; Forstner, AJ; Frisen, L; Frye, MA; Fullerton, JM; Gard, S; Garnham, JS; Goes, FS; Grigoroiu-Serbanescu, M; Grof, P; Hashimoto, R; Hauser, J; Heilbronner, U; Herms, S; Hoffmann, P; Hofmann, A; Hou, L; Hsu, YH; Jamain, S; Jiménez, E; Kahn, JP; Kassem, L; Kato, T; Kelsoe, JR; Kittel-Schneider, S; Kliwicki, S; König, B; Kuo, PH; Kusumi, I; Laje, G; Landén, M; Lavebratt, C; Leboyer, M; Leckband, SG; Maj, M; Manchia, M; Martinsson, L; McCarthy, MJ; McElroy, SL; McMahon, FJ; Mitchell, PB; Mitjans, M; Mondimore, FM; Monteleone, P; Nievergelt, CM; Nöthen, MM; Novák, T; O'Donovan, C; Ösby, U; Ozaki, N; Papiol, S; Pfennig, A; Potash, JB; Reif, A; Reininghaus, E; Rietschel, M; Rouleau, GA; Rybakowski, JK; Schalling, M; Schofield, PR; Schubert, KO; Schulze, TG; Schweizer, BW; Severino, G; Shekhtman, T; Shilling, PD; Shimoda, K; Simhandl, C; Slaney, CM; Squassina, A; Stamm, T; Stopkova, P; Tekola-Ayele, F; Tortorella, A; Turecki, G; Veeh, J; Vieta, E; Witt, SH; Wright, A; Zandi, PP1
Cao, JL; Ding, HL; Han, MH; Hu, SW; Liu, D; Liu, H; Montgomery, SE; Song, SP; Tang, QQ; Wang, D; Wang, ZY; Xu, Z; Yang, JX; Yang, XN; Zhang, H1
Berk, M; Brietzke, E; Goldstein, BI; Kessing, LV; López-Jaramillo, C; Majeed, A; Malhi, GS; Mansur, RB; McIntyre, RS; Nierenberg, AA; Rosenblat, JD; Vieta, E; Vinberg, M; Young, AH1
Detraux, J; Lambrichts, S; Nordenskjöld, A; Obbels, J; Schrijvers, D; Sienaert, P; Vansteelandt, K1
Ågren, H; Aigner, L; Funa, K; Hanse, E; Iljin, M; Illes, S; Izsak, J; Seth, H; Theiss, S1
Hashimoto, K; Hashimoto, R; Hashimoto, T; Hata, T; Hattori, K; Hishimoto, A; Horai, T; Idemoto, K; Ishima, T; Iyo, M; Kameno, Y; Kikuchi, M; Kimura, A; Minabe, Y; Mori, N; Nakagome, K; Niitsu, T; Oda, Y; Ota, K; Otsuka, I; Toda, S; Yamamori, H; Yoshida, S1
Alexopoulos, G; Bailine, SH; Bernhardt, E; Briggs, MC; Cullum, CM; Deng, ZD; Geduldig, ET; Greenberg, RM; Husain, MM; Kaliora, S; Kellner, CH; Knapp, RG; Latoussakis, V; Liebman, LS; Lisanby, SH; McCall, WV; McClintock, SM; Mueller, M; Petrides, G; Prudic, J; Rosenquist, PB; Rudorfer, MV; Sampson, S; Teklehaimanot, AA; Tobias, KG; Weiner, RD; Young, RC1
Aljurdi, RK; Banerjee, S; Evans, LD; Gildengers, AG; Gur, RC; Gyulai, L; Marino, P; Mulsant, BH; Sajatovic, M; Schulberg, HC; Young, RC1
Hoti, F; Lähteenvuo, M; Mehtälä, J; Taipale, H; Tanskanen, A; Tiihonen, J; Vattulainen, P1
Young, AH1
Attenburrow, MJ; Cipriani, A; Cleare, AJ; Dietch, D; Geddes, J; Goldsmith, K; Holland, R; Hutchinson, J; Marwood, L; McAllister-Williams, RH; Nair, R; Pickles, A; Romeo, R; Taylor, R; Young, AH1
Daniels, PF; Hincapie-Castillo, JM1
Tiihonen, J1
Adli, M; Bauer, M; Bopp, S; Borgwardt, S; Bschor, T; Elstner, S; Heinz, A; Hellweg, R; Himmerich, H; Lang, UE; Lingesleben, A; Reischies, FM; Richter, C; Ricken, R; Schlattmann, P; Schulz-Ratei, B; Stamm, TJ; Sterzer, P1
Baldessarini, RJ; Tondo, L; Vázquez, GH1
Carvalho, AF; Hidalgo-Mazzei, D; Murru, A; Pacchiarotti, I; Samalin, L; Verdolini, N; Vieta, E; Young, AH1
Bergink, V; Brown, HK; D'Onofrio, BM; Di Florio, A; Gomes, T; Howard, LM; Khalifeh, H; Krohn, H; Larsson, H; Lichtenstein, P; Liu, X; Meltzer-Brody, S; Munk-Olsen, T; Taylor, CL; Van Kamp, I; Vigod, SN; Viktorin, A; Wesseloo, R1
Martino, DJ; Valerio, MP1
Adli, M; Bopp, SK; Bschor, T; Cichon, S; Heilbronner, U; Heinz, A; Hellweg, R; Herms, S; Köhler, S; Lang, UE; Merkl, A; Mühleisen, TW; Richter, C; Ricken, R; Schlattmann, P; Schulze, TG; Stamm, TJ; Steinacher, B; Sterzer, P1
Berrocoso, E; González-Saiz, F; Mico, JA; Perez-Caballero, L; Romero-López-Alberca, C; Torres-Sanchez, S1
Brunkhorst-Kanaan, N; Geisslinger, G; Hackel, J; Hahnefeld, L; Kittel-Schneider, S; Klatt-Schreiner, K; Reif, A; Schröter, K; Tegeder, I; Thomas, D; Trautmann, S; Wicker, S1
Bauer, M; Dell'osso, L; Dencker Vansvik, E; Jørgensen, L; Kasper, S; Köhler, J; Montgomery, SA; Pitchot, W1
Benedetti, F; Colombo, C; Dallaspezia, S; Locatelli, C; Poletti, S; Riccaboni, R1
Angst, J; Bauer, M; Köhler, S; Möller, HJ; Severus, E; Whybrow, PC1
Bauer, M; Conell, J; Djawid, B; Fülle, M; Goodday, S; Gruber, O; Haussmann, R; Holthoff, V; Jabs, B; Juckel, G; Kittel-Schneider, S; Lewitzka, U; Pfennig, A; Reif, A; Reif-Leonhard, C; Ritter, P; Severus, E; Uhl, I1
Corruble, E; Costemale-Lacoste, J; Gaillard, R; Mouaffak, F1
Otter, M; van Amelsvoort, TA1
Coffey, MJ; Stevens, JR1
Adli, M; Bauer, F; Bopp, S; Bschor, T; Heinz, A; Hellweg, R; Himmerich, H; Lang, UE; Richter, C; Ricken, R; Schlattmann, P; Stamm, TJ1
Anghelescu, IG; Correll, CU; Gao, K; Normann, C; Reis, C; Schaffer, A; Solmi, M; van der Loos, ML; Veronese, N; Zaninotto, L1
Aggio, V; Ambrée, O; Arolt, V; Benedetti, F; Colombo, C; de Wit, H; Drexhage, HA; Hoogenboezem, TA; Locatelli, C; Poletti, S; Wijkhuijs, AJ1
Luckenbaugh, DA; Niciu, MJ; Pennybaker, SJ; Zarate, CA1
De-Paula, VJ; Forlenza, OV; Gattaz, WF1
Allison, S; Bastiampillai, T; Chan, SKW; Gupta, A1
Brisbane, DS; Cherry, S; Lie, D; Spivak, V; Wysoczanski, D1
Beaulieu, JM; Bureau, A; Chagnon, YC; Maziade, M; Paccalet, T1
Adli, M; Baethge, C; Bauer, M; Bschor, T; Ising, M; Lewitzka, U; Lucka, C; Mueller-Oerlinghausen, B; Uhr, M1
Amsterdam, JD; Shults, J; Wang, G1
Dwivedi, Y; Pandey, GN; Ren, X; Rizavi, HS1
Burt, VK; Ritchie, HL; Sharma, V1
Chilakamarri, G; Weismantel, A; Weismantel, D1
Nolen, WA; Spijker, J1
Baldessarini, RJ; Tondo, L; Vázquez, G1
Haskett, R; Isenberg, K; Kimball, J; Lasater, B; McCall, WV; Prudic, J; Rosenquist, PB; Sackeim, HA1
Chappell, PB; Gurtovaya, O; Ice, KS; Kasuba, B; Sachs, GS; Schwartz, JH; Vanderburg, DG1
Bschor, T; Erbe, S; Ising, M; Lewitzka, U; Ritter, D; Uhr, M; Winkelmann, P1
Albayram, Ö; Bilkei-Gorzo, A; Breuer, R; Cichon, S; Degenhardt, FA; Dreisow, ML; Frank, J; Mattheisen, M; Meier, S; Miró, X; Mühleisen, TW; Nöthen, MM; Pardo-Olmedilla, MT; Reinhard, I; Rietschel, M; Schmäl, C; Seidenbecher, C; Strohmaier, J; Zimmer, A1
Jackson, WC; Jain, R1
Brus, O; Carlborg, A; Engström, I; Ljung, T; Nordenskjöld, A; von Knorring, L1
Cusin, C; Lucca, A; Mandelli, L; Serretti, A; Smeraldi, E1
Beersma, DG; den Boer, JA; Dols, LC; Mersch, PP; van den Hoofdakker, RH1
Müller-Oerlinghausen, B; Wolf, T1
Bowley, MP; Drevets, WC; Ongür, D; Price, JL1
Alpert, JE; Fava, M; Montoya, HD; Nierenberg, AA; Papakostas, GI; Petersen, T; Tedlow, J; Worthington, JJ1
Caviness, JN; Evidente, VG1
Rothschild, AJ1
Chidori, S; Nishimura, R1
Kaji, K; Nakamura, J; Yoshimura, R1
Higuchi, H1
Bauer, M; Bschor, T2
Birkenhäger, TK; Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW2
Klibanski, A; Misra, M; Papakostas, GI1
Basinski, J; Begley, A; Dew, MA; Farhi, P; Mulsant, BH; Reynolds, CF; Whyte, EM1
Kobayashi, N; Nomura, S; Sawamura, T; Yoshida, T; Yoshino, A1
Bares, M; Kopecek, M; Mohr, P1
Maggini, C; Marchesi, C; Paini, M1
Henn, FA; Sartorius, A; Wolf, J1
Bickel, A; Kornhuber, J; Maihöfner, C; Ropohl, A1
De Pradier, M; Goldberger, C1
Valenstein, M1
Birkenhäger, TK; Bruijn, JA; Moleman, P; van den Broek, WW1
Kvale, JN1
Cairoli, S; Tosca, P; Zerbi, F1
Dörr-Zegers, O; Tellenbach, H1
Alda, M; Deshauer, D; Grof, E; Grof, P1
Bauer, M; Bschor, T; Canata, B; Müller-Oerlinghausen, B1
Chen, B; Dowlatshahi, D; MacQueen, GM; Stewart, RJ; Young, LT1
Cusin, C; Lattuada, E; Lilli, R; Lorenzi, C; Rossini, D; Serretti, A; Smeraldi, E; Zanardi, R1
Bech, P; Geisler, A; Johannesen, M; Rafaelsen, OJ1
Freedman, R; Schwab, PJ1
Boscredon, J; Oulès, J1
Akiskal, HS; McKinney, WT1
de Hooge, JK1
Savitsky, E1
Edgell, PG; Peterfy, G; Pinter, EJ1
Nakaya, K; Otsuki, S; Taguchi, K; Watanabe, S1
Angst, J; Baastrup, PC; Grof, P; Schou, M; Weis, P1
Náhunek, K; Rodová, A; Svestka, J2
Bell, GO; Tucker, WI1
Aimard, G; Chazot, G; Devic, M; Eyssette, M; Fournis, Y1
Náhunek, K; Novotná, D; Rodová, A; Svestka, J1

Reviews

20 review(s) available for lithium and Depressive Disorder, Major

ArticleYear
Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients.
    Translational psychiatry, 2021, 11-29, Volume: 11, Issue:1

    Topics: Bipolar Disorder; Depression; Depressive Disorder, Major; Genetic Predisposition to Disease; Humans; Lithium; Multifactorial Inheritance; Risk Factors; Schizophrenia

2021
Bipolar disorders.
    Lancet (London, England), 2020, 12-05, Volume: 396, Issue:10265

    Topics: Adolescent; Adult; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Cardiovascular Diseases; Child; Child Abuse; Comorbidity; Depressive Disorder, Major; Environmental Exposure; Humans; Lamotrigine; Lithium; Mania; Suicide; Suicide Prevention; Valproic Acid; Young Adult

2020
Does lithium prevent relapse following successful electroconvulsive therapy for major depression? A systematic review and meta-analysis.
    Acta psychiatrica Scandinavica, 2021, Volume: 143, Issue:4

    Topics: Depression; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Lithium; Prospective Studies; Recurrence; Retrospective Studies

2021
Pharmacological treatment of adult bipolar disorder.
    Molecular psychiatry, 2019, Volume: 24, Issue:2

    Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Humans; Lithium; Lithium Compounds

2019
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
    Acta psychiatrica Scandinavica, 2018, Volume: 138, Issue:3

    Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Thiazoles; Valproic Acid

2018
Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies.
    The lancet. Psychiatry, 2018, Volume: 5, Issue:8

    Topics: Adult; Bipolar Disorder; Cohort Studies; Depressive Disorder, Major; Europe; Female; Global Health; Humans; Infant, Newborn; Lithium; Ontario; Pregnancy; Pregnancy Complications; United States

2018
Differential response to lithium between melancholic and non-melancholic unipolar depression.
    Psychiatry research, 2018, Volume: 269

    Topics: Adult; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Lithium; Male; Middle Aged; Treatment Outcome

2018
Monoaminergic system and depression.
    Cell and tissue research, 2019, Volume: 377, Issue:1

    Topics: Antidepressive Agents; Antipsychotic Agents; Biogenic Monoamines; Buspirone; Depressive Disorder, Major; Drug Synergism; Excitatory Amino Acid Agents; Humans; Lithium; Pindolol; Triiodothyronine

2019
Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    CNS spectrums, 2016, Volume: 21, Issue:5

    Topics: Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Citalopram; Depression; Depressive Disorder, Major; Drug Combinations; Fluoxetine; Humans; Inositol; Lamotrigine; Lithium; Triazines; Vitamin B Complex

2016
Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.
    Journal of affective disorders, 2017, Jan-15, Volume: 208

    Topics: Adult; Alcohol-Related Disorders; Antidepressive Agents; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Infusions, Intravenous; Ketamine; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome; Valproic Acid

2017
Assessment and treatment of bipolar II postpartum depression: a review.
    Journal of affective disorders, 2010, Volume: 125, Issue:1-3

    Topics: Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Combined Modality Therapy; Depression, Postpartum; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Evidence-Based Medicine; Female; Humans; Lithium; Mass Screening; Pregnancy; Psychotherapy; Recurrence

2010
Mania associated with antidepressant treatment: comprehensive meta-analytic review.
    Acta psychiatrica Scandinavica, 2010, Volume: 121, Issue:6

    Topics: Adult; Age Factors; Antidepressive Agents, Tricyclic; Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Humans; Lithium; Middle Aged; Models, Statistical; Risk Factors; Selective Serotonin Reuptake Inhibitors; Time Factors

2010
Challenges in the treatment of depression with psychotic features.
    Biological psychiatry, 2003, Apr-15, Volume: 53, Issue:8

    Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Electroconvulsive Therapy; Family; Glucocorticoids; Humans; Hydrocortisone; Lithium; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors

2003
[Mood disorder in childhood and adolescence].
    Ryoikibetsu shokogun shirizu, 2003, Issue:38

    Topics: Bipolar Disorder; Carbamazepine; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lithium; Psychotherapy; Psychotropic Drugs; Reference Standards

2003
[Double depression].
    Ryoikibetsu shokogun shirizu, 2003, Issue:38

    Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Disease Progression; Drug Therapy, Combination; Fluvoxamine; Humans; Lithium; Male; Middle Aged; Psychotherapy; Reference Standards; Selective Serotonin Reuptake Inhibitors

2003
[Postpsychotic depressive disorder].
    Ryoikibetsu shokogun shirizu, 2003, Issue:38

    Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Humans; Lithium; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors

2003
Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:12

    Topics: Adult; Anticonvulsants; Bipolar Disorder; Bone and Bones; Bone Density; Comorbidity; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Hyperprolactinemia; Hypogonadism; Lithium; Male; Mental Disorders; Osteoporosis; Prolactin; Psychotic Disorders; Psychotropic Drugs; Schizophrenia

2004
Efficacy and mechanisms of action of lithium augmentation in refractory major depression.
    Current pharmaceutical design, 2006, Volume: 12, Issue:23

    Topics: Animals; Antidepressive Agents; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium

2006
Overview of recent research in depression. Integration of ten conceptual models into a comprehensive clinical frame.
    Archives of general psychiatry, 1975, Volume: 32, Issue:3

    Topics: Anger; Animals; Anxiety, Separation; Behavior; Bipolar Disorder; Cognition; Depression; Depressive Disorder, Major; Diagnosis, Differential; Disease Models, Animal; Feedback; Happiness; Humans; Lithium; Models, Psychological; Monoamine Oxidase Inhibitors; Prognosis; Research; Self Concept; Stress, Psychological; Terminology as Topic

1975
[Antidepressive agents in the elderly].
    Tijdschrift voor gerontologie en geriatrie, 1990, Volume: 21, Issue:6

    Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depressive Disorder; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Lithium; Monoamine Oxidase Inhibitors

1990

Trials

24 trial(s) available for lithium and Depressive Disorder, Major

ArticleYear
Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder: A Randomized Clinical Trial.
    JAMA psychiatry, 2022, 01-01, Volume: 79, Issue:1

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Lithium; Male; Middle Aged; Outcome Assessment, Health Care; Suicidal Ideation; Suicide, Attempted; Veterans

2022
Adjunctive lumateperone (ITI-007) in the treatment of bipolar depression: Results from a randomized placebo-controlled clinical trial.
    Bipolar disorders, 2023, Volume: 25, Issue:6

    Topics: Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Humans; Lithium; Treatment Outcome; Valproic Acid

2023
Estimating the per-protocol effect of lithium on suicidality in a randomized trial of individuals with depression or bipolar disorder.
    Journal of psychopharmacology (Oxford, England), 2023, Volume: 37, Issue:6

    Topics: Bipolar Disorder; Depression; Depressive Disorder, Major; Humans; Lithium; Randomized Controlled Trials as Topic; Suicide

2023
Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2022, Volume: 30, Issue:1

    Topics: Aged; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Lithium; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride

2022
Assessing bipolar disorder in the older adult: the GERI-BD toolbox.
    International journal of geriatric psychiatry, 2018, Volume: 33, Issue:1

    Topics: Aged; Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium; Male; Middle Aged; Mood Disorders; Valproic Acid

2018
Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study).
    BMC psychiatry, 2017, 06-26, Volume: 17, Issue:1

    Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Cost-Benefit Analysis; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Humans; Lithium; Quetiapine Fumarate

2017
Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
    Journal of affective disorders, 2013, Volume: 151, Issue:1

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Delayed-Action Preparations; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Lithium; Lithium Compounds; Male; Middle Aged; Psychiatric Status Rating Scales; Quetiapine Fumarate; Treatment Outcome; Young Adult

2013
Does lithium reduce acute suicidal ideation and behavior? A protocol for a randomized, placebo-controlled multicenter trial of lithium plus Treatment As Usual (TAU) in patients with suicidal major depressive episode.
    BMC psychiatry, 2015, May-19, Volume: 15

    Topics: Adult; Clinical Protocols; Depressive Disorder, Major; Female; Humans; Lithium; Male; Middle Aged; Suicidal Ideation; Suicide; Suicide Prevention; Treatment Outcome

2015
Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.
    The journal of ECT, 2011, Volume: 27, Issue:2

    Topics: Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Middle Aged; Nortriptyline; Quality of Life; Time Factors; Venlafaxine Hydrochloride

2011
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    The Journal of clinical psychiatry, 2011, Volume: 72, Issue:10

    Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium; Male; Middle Aged; Piperazines; Serotonin Antagonists; Thiazoles; Treatment Outcome; Triazines; Valproic Acid; Young Adult

2011
Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients.
    PloS one, 2011, Volume: 6, Issue:11

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Corticotropin-Releasing Hormone; Demography; Depressive Disorder, Major; Dexamethasone; Diagnostic Techniques and Procedures; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Lithium; Male; Middle Aged; Treatment Outcome; Young Adult

2011
Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial.
    The journal of ECT, 2013, Volume: 29, Issue:2

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antimanic Agents; Cognition; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Sample Size; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride

2013
The influence of successful prophylactic drug treatment on cognitive dysfunction in bipolar disorders.
    Bipolar disorders, 2002, Volume: 4, Issue:4

    Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Cognition Disorders; Depressive Disorder, Major; Female; Humans; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Remission Induction; Self Concept

2002
Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants.
    Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:1

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales

2003
Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder.
    The American journal of psychiatry, 2004, Volume: 161, Issue:11

    Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluvoxamine; Hospitalization; Humans; Imipramine; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome

2004
Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:12

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

2004
Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:2

    Topics: Adult; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Hospitalization; Humans; Imipramine; Lithium; Male; Middle Aged; Monoamine Oxidase Inhibitors; Outcome Assessment, Health Care; Placebos; Proportional Hazards Models; Psychiatric Status Rating Scales; Risk Factors; Secondary Prevention; Treatment Outcome

2006
Keeping our eyes on STAR*D.
    The American journal of psychiatry, 2006, Volume: 163, Issue:9

    Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Placebos; Research Design; Tranylcypromine; Treatment Outcome; Triiodothyronine; Venlafaxine Hydrochloride

2006
Outcome of a 4-step treatment algorithm for depressed inpatients.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:8

    Topics: Adult; Aged; Algorithms; Antidepressive Agents; Clinical Protocols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Electroconvulsive Therapy; Feasibility Studies; Female; Hospitalization; Humans; Lithium; Longitudinal Studies; Male; Middle Aged; Monoamine Oxidase Inhibitors; Patient Compliance; Patient Dropouts; Psychiatric Status Rating Scales; Treatment Outcome

2006
Patterns of DST positivity in remitted affective disorders.
    Biological psychiatry, 1999, Apr-15, Volume: 45, Issue:8

    Topics: Adult; Aged; Antimanic Agents; Bipolar Disorder; Cross-Sectional Studies; Depressive Disorder, Major; Dexamethasone; Female; Glucocorticoids; Humans; Hypothalamo-Hypophyseal System; Lithium; Male; Middle Aged; Pituitary-Adrenal System; Remission Induction; Seasons; Severity of Illness Index

1999
Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
    The international journal of neuropsychopharmacology, 2002, Volume: 5, Issue:1

    Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Second-Generation; Antimanic Agents; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Female; Fluvoxamine; Genotype; Humans; Lithium; Male; Middle Aged; Monoamine Oxidase; Paroxetine; Pindolol; Polymorphism, Genetic; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Sex Characteristics

2002
Psychopharmacology in the aged. Discussion.
    Journal of geriatric psychiatry, 1974, Volume: 7, Issue:2

    Topics: Age Factors; Aged; Amitriptyline; Antipsychotic Agents; Bipolar Disorder; Brain Damage, Chronic; Depressive Disorder, Major; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hospital Design and Construction; Hospitals, Psychiatric; Humans; Informed Consent; Lithium; Male; Mental Disorders; Perphenazine; Personality; Placebos; Psychopharmacology

1974
Lithium prophylaxis in recurrent affective disorders.
    The British journal of psychiatry : the journal of mental science, 1970, Volume: 116, Issue:535

    Topics: Adolescent; Adult; Affective Symptoms; Aged; Bipolar Disorder; Child; Clinical Trials as Topic; Depression; Depressive Disorder, Major; Female; Humans; Lithium; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychotic Disorders; Statistics as Topic

1970
To the antidepressive properties of lithium and its place in the group of antidepressive drugs.
    Activitas nervosa superior, 1971, Volume: 13, Issue:3

    Topics: Antidepressive Agents; Bipolar Disorder; Carbonates; Clinical Trials as Topic; Coma; Depression; Depressive Disorder, Major; History, 15th Century; History, 16th Century; History, 17th Century; History, 18th Century; Humans; Hypnotics and Sedatives; Lithium; Movement Disorders; Placebos; Pruritus; Psychiatric Status Rating Scales

1971

Other Studies

66 other study(ies) available for lithium and Depressive Disorder, Major

ArticleYear
A GWAS top hit for circulating leptin is associated with weight gain but not with leptin protein levels in lithium-augmented patients with major depression.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2021, Volume: 53

    Topics: Body Mass Index; Depression; Depressive Disorder, Major; Genome-Wide Association Study; Humans; Leptin; Lithium; Polymorphism, Single Nucleotide; Weight Gain

2021
A letter to the editor, associated with the article entitled "Efficacy and tolerability of combination treatments for major depression: Antidepressants plus second-generation antipsychotics vs esketamine vs lithium" by Vázquez et al. (
    Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:5

    Topics: Antidepressive Agents; Antipsychotic Agents; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Ketamine; Lithium; Psychopharmacology

2022
Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach - CORRIGENDUM.
    The British journal of psychiatry : the journal of mental science, 2022, Volume: 221, Issue:2

    Topics: Bipolar Disorder; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Humans; Lithium; Machine Learning

2022
Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway.
    Zoological research, 2022, Nov-18, Volume: 43, Issue:6

    Topics: Animals; Antidepressive Agents; Depressive Disorder, Major; Ketamine; Lithium; Lithium Compounds; Male; Mammals; Mania; Mice; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Rodent Diseases; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2022
Inflammation and damage-associated molecular patterns in major psychiatric disorders.
    Trends in psychiatry and psychotherapy, 2023, Volume: 45

    Topics: Bipolar Disorder; Clozapine; Depressive Disorder, Major; HSP70 Heat-Shock Proteins; Humans; Inflammation; Lithium

2023
Lumateperone Normalizes Pathological Levels of Acute Inflammation through Important Pathways Known to Be Involved in Mood Regulation.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2023, 02-01, Volume: 43, Issue:5

    Topics: Animals; Cytokines; Depressive Disorder, Major; Female; Inflammation; Lithium; Male; Mammals; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; TOR Serine-Threonine Kinases; Valproic Acid

2023
When and How to Use Lithium Augmentation for Treating Major Depressive Disorder.
    The Journal of clinical psychiatry, 2023, 03-08, Volume: 84, Issue:2

    Topics: Antidepressive Agents; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Lithium Carbonate

2023
Electroconvulsive therapy plus lithium is associated with less cognitive impairment and drug-induced delirium in bipolar depression compared to unipolar depression.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2023, Volume: 35, Issue:2

    Topics: Adult; Bipolar Disorder; Cognitive Dysfunction; Delirium; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Lithium; Treatment Outcome

2023
Association of Bipolar Disorder Diagnosis With Suicide Mortality Rates in Adolescents in Sweden.
    JAMA psychiatry, 2023, 08-01, Volume: 80, Issue:8

    Topics: Adolescent; Bipolar Disorder; Cross-Sectional Studies; Depressive Disorder, Major; Female; Humans; Lithium; Male; Suicide; Sweden

2023
Lithium treatment versus hospitalization in bipolar disorder and major depression patients.
    Journal of affective disorders, 2023, 11-01, Volume: 340

    Topics: Bipolar Disorder; Depression; Depressive Disorder, Major; Hospitalization; Humans; Lithium; Lithium Compounds; Retrospective Studies; Substance-Related Disorders

2023
Polygenic risk scores of lithium response and treatment resistance in major depressive disorder.
    Translational psychiatry, 2023, 09-28, Volume: 13, Issue:1

    Topics: Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Electroconvulsive Therapy; Humans; Lithium

2023
Re: "The Impact of Placebo Response Rates on Clinical Trial Outcome: A Systematic Review and Meta-Analysis of Antidepressants in Children and Adolescents with Major Depressive Disorder" by Li Y, Huang J, He Y, Yang J, Lv Y, Liu H, Liang L, Zheng Q, and Li
    Journal of child and adolescent psychopharmacology, 2020, Volume: 30, Issue:1

    Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Humans; Lithium; Male; Placebo Effect

2020
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder.
    Molecular psychiatry, 2021, Volume: 26, Issue:6

    Topics: Bipolar Disorder; Depression; Depressive Disorder, Major; Genome-Wide Association Study; Humans; Lithium

2021
Mesocortical BDNF signaling mediates antidepressive-like effects of lithium.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2020, Volume: 45, Issue:9

    Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Lithium; Mice; Nucleus Accumbens; Prefrontal Cortex; Ventral Tegmental Area

2020
Differential acute impact of therapeutically effective and overdose concentrations of lithium on human neuronal single cell and network function.
    Translational psychiatry, 2021, 05-12, Volume: 11, Issue:1

    Topics: Action Potentials; Depressive Disorder, Major; Humans; Induced Pluripotent Stem Cells; Lithium; Neurons

2021
Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response.
    Psychiatry research, 2021, Volume: 301

    Topics: Biomarkers; Cross-Sectional Studies; Depressive Disorder, Major; Glial Cell Line-Derived Neurotrophic Factor; Humans; Lithium; Mood Disorders

2021
Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study.
    The lancet. Psychiatry, 2017, Volume: 4, Issue:7

    Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Antipsychotic Agents; Clozapine; Cohort Studies; Depressive Disorder; Depressive Disorder, Major; Female; Finland; Humans; Incidence; Lithium; Male; Middle Aged; Outcome Assessment, Health Care; Patient Readmission; Risk; Secondary Prevention; Severity of Illness Index

2017
Lithium for long-term treatment of unipolar depression.
    The lancet. Psychiatry, 2017, Volume: 4, Issue:7

    Topics: Bipolar Disorder; Cohort Studies; Depressive Disorder, Major; Finland; Humans; Lithium; Patient Readmission

2017
Use of lithium in patients with unipolar depression.
    The lancet. Psychiatry, 2017, Volume: 4, Issue:9

    Topics: Bipolar Disorder; Cohort Studies; Depressive Disorder, Major; Finland; Humans; Lithium; Patient Readmission

2017
Use of lithium in patients with unipolar depression - Author's reply.
    The lancet. Psychiatry, 2017, Volume: 4, Issue:9

    Topics: Cohort Studies; Depressive Disorder, Major; Finland; Humans; Lithium; Patient Readmission

2017
Ghrelin Serum Concentrations Are Associated with Treatment Response During Lithium Augmentation of Antidepressants.
    The international journal of neuropsychopharmacology, 2017, 09-01, Volume: 20, Issue:9

    Topics: Adult; Aged; Antidepressive Agents; Body Mass Index; Cohort Studies; Depressive Disorder, Major; Female; Ghrelin; Humans; Lithium; Male; Middle Aged; Time Factors

2017
Leptin gene polymorphisms are associated with weight gain during lithium augmentation in patients with major depression.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2019, Volume: 29, Issue:2

    Topics: Adult; Depressive Disorder, Major; Female; Genotype; Humans; Ideal Body Weight; Leptin; Lithium; Male; Middle Aged; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Retrospective Studies; Weight Gain

2019
Targeted lipidomics reveal derangement of ceramides in major depression and bipolar disorder.
    Metabolism: clinical and experimental, 2019, Volume: 95

    Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Body Mass Index; Ceramides; Depressive Disorder, Major; Diglycerides; Female; Humans; Lipid Metabolism; Lithium; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Sex Characteristics; Triglycerides; Young Adult

2019
Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression.
    The Journal of clinical psychiatry, 2014, Volume: 75, Issue:2

    Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Chronotherapy; Combined Modality Therapy; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Resistance; Female; Humans; Lithium; Male; Middle Aged; Phototherapy; Severity of Illness Index; Sleep Deprivation; Suicide Prevention; Time Factors; Treatment Outcome

2014
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2015, Volume: 16, Issue:2

    Topics: Antidepressive Agents; Antipsychotic Agents; Biological Psychiatry; Carbamazepine; Depressive Disorder, Major; Dibenzothiazepines; Drug Therapy, Combination; Electroconvulsive Therapy; Evidence-Based Medicine; Humans; Lithium; Plant Extracts; Psychotherapy; Quetiapine Fumarate

2015
Is Polyuria a Predictive Sign of Lithium Response in Major Depression?
    Journal of clinical psychopharmacology, 2015, Volume: 35, Issue:4

    Topics: Depressive Disorder, Major; Humans; Lithium; Polyuria; Predictive Value of Tests; Treatment Outcome

2015
[Lithium therapy in patients with mild mental retardation].
    Tijdschrift voor psychiatrie, 2015, Volume: 57, Issue:7

    Topics: Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Comorbidity; Depressive Disorder, Major; Disability Evaluation; Female; Humans; Intellectual Disability; Lithium; Mental Health Services; Middle Aged; Severity of Illness Index; Treatment Outcome; Young Adult

2015
Safe and Successful ECT in a Female-to-Male Transgender Individual With Major Depression.
    The journal of ECT, 2016, Volume: 32, Issue:3

    Topics: Adult; Antimanic Agents; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Psychiatric Status Rating Scales; Sex Reassignment Procedures; Suicidal Ideation; Transgender Persons

2016
Leptin serum concentrations are associated with weight gain during lithium augmentation.
    Psychoneuroendocrinology, 2016, Volume: 71

    Topics: Adult; Aged; Body Mass Index; Body Weight; Cohort Studies; Depressive Disorder, Major; Female; Humans; Leptin; Lithium; Male; Middle Aged; Obesity; Prospective Studies; Weight Gain

2016
Brain-derived Neurotrophic Factor (BDNF) and gray matter volume in bipolar disorder.
    European psychiatry : the journal of the Association of European Psychiatrists, 2017, Volume: 40

    Topics: Adult; Biomarkers; Bipolar Disorder; Brain; Brain-Derived Neurotrophic Factor; Case-Control Studies; Cerebral Cortex; Depressive Disorder, Major; Female; Gray Matter; Gyrus Cinguli; Humans; Lithium; Male; Middle Aged

2017
Long-term lithium treatment increases intracellular and extracellular brain-derived neurotrophic factor (BDNF) in cortical and hippocampal neurons at subtherapeutic concentrations.
    Bipolar disorders, 2016, Volume: 18, Issue:8

    Topics: Animals; Antimanic Agents; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cerebral Cortex; Depressive Disorder, Major; Disease Models, Animal; Hippocampus; Lithium; Long Term Adverse Effects; Neurons; Neuroprotective Agents; Rats

2016
Lithium, suicide prevention and unipolar depression?
    The Australian and New Zealand journal of psychiatry, 2017, Volume: 51, Issue:8

    Topics: Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Humans; Lithium; Suicide

2017
Lithium augmentation as an alternative to maintenance electroconvulsive therapy for recurrent major depressive disorder in older adults.
    Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2017, Volume: 25, Issue:1

    Topics: Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Treatment Outcome

2017
The interaction of GSK3B and FXR1 genotypes may influence the mania and depression dimensions in mood disorders.
    Journal of affective disorders, 2017, Apr-15, Volume: 213

    Topics: Adult; Age of Onset; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Genotype; Glycogen Synthase Kinase 3 beta; Humans; Lithium; Male; Middle Aged; Mood Disorders; Polymorphism, Genetic; Prevalence; RNA-Binding Proteins

2017
Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.
    Neuropsychobiology, 2009, Volume: 60, Issue:1

    Topics: Adrenocorticotropic Hormone; Corticotropin-Releasing Hormone; Depressive Disorder, Major; Dexamethasone; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Lithium; Male; Middle Aged; Pituitary-Adrenal System; Psychotropic Drugs; Recurrence; Time Factors; Treatment Outcome

2009
Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy.
    Acta psychiatrica Scandinavica, 2010, Volume: 121, Issue:3

    Topics: Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Female; Humans; Lithium; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult

2010
Glycogen synthase kinase-3beta in the platelets of patients with mood disorders: effect of treatment.
    Journal of psychiatric research, 2010, Volume: 44, Issue:3

    Topics: Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Blood Platelets; Cell Membrane; Cytosol; Depressive Disorder, Major; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lithium

2010
Can nonantidepressants help treat depression?
    The Journal of family practice, 2009, Volume: 58, Issue:10

    Topics: Antidepressive Agents; Antipsychotic Agents; Cohort Studies; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Triiodothyronine

2009
An algorithm for the pharmacological treatment of depression.
    Acta psychiatrica Scandinavica, 2010, Volume: 121, Issue:3

    Topics: Algorithms; Antidepressive Agents; Antimanic Agents; Combined Modality Therapy; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Electroconvulsive Therapy; Humans; Lithium; MEDLINE; Meta-Analysis as Topic; Monoamine Oxidase Inhibitors; Netherlands; Practice Guidelines as Topic; Randomized Controlled Trials as Topic

2010
Studies in humans and mice implicate neurocan in the etiology of mania.
    The American journal of psychiatry, 2012, Volume: 169, Issue:9

    Topics: Alleles; Animals; Behavior, Animal; Bipolar Disorder; Depressive Disorder, Major; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Lithium; Male; Mice; Mice, Knockout; Neurocan; Principal Component Analysis; Schizophrenia

2012
Beyond the resistance: how novel neurobiological understandings of depression may lead to advanced treatment strategies.
    The Journal of clinical psychiatry, 2012, Volume: 73, Issue:11

    Topics: Adult; Alleles; Antidepressive Agents; Brain; Coenzymes; Controlled Clinical Trials as Topic; Cytokines; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; DNA Mutational Analysis; Drug Therapy, Combination; Genetic Predisposition to Disease; Humans; Inflammation Mediators; Lithium; Magnetic Resonance Imaging; Methylenetetrahydrofolate Reductase (NADPH2); Nerve Growth Factors; Obesity; Obesity, Abdominal; Polymorphism, Genetic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Tetrahydrofolates; Waist Circumference

2012
Seasonal variations of lithium plasma levels.
    Psychiatry research, 2002, Aug-05, Volume: 111, Issue:1

    Topics: Adult; Bipolar Disorder; Depressive Disorder, Major; Erythrocytes; Female; Humans; Lithium; Male; Middle Aged; Seasons

2002
Lithium concentrations in plasma of lithium-treated psychiatric patients in the Netherlands: commentary on Cusin et al.
    Psychiatry research, 2002, Aug-05, Volume: 111, Issue:1

    Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Italy; Lithium; Male; Netherlands; Seasons

2002
Low glial numbers in the amygdala in major depressive disorder.
    Biological psychiatry, 2002, Sep-01, Volume: 52, Issue:5

    Topics: Amygdala; Anticonvulsants; Bipolar Disorder; Cell Count; Cell Size; Depressive Disorder, Major; Entorhinal Cortex; Humans; Lithium; Neuroglia; Neurons; Valproic Acid

2002
Cortical myoclonus during lithium exposure.
    Archives of neurology, 2003, Volume: 60, Issue:3

    Topics: Adult; Aged; Bipolar Disorder; Cerebral Cortex; Depressive Disorder, Major; Electroencephalography; Electromyography; Female; Humans; Lithium; Male; Middle Aged; Myoclonus; Retrospective Studies

2003
Is successful lithium augmentation limited to serotonergic antidepressants?
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:2

    Topics: Antimanic Agents; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Selective Serotonin Reuptake Inhibitors; Treatment Failure

2004
The effectiveness of lithium augmentation of milnacipran: preliminary data using the modified Japanese Psychopharmacology Algorithm.
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2004, Volume: 24, Issue:5

    Topics: Adrenergic Uptake Inhibitors; Algorithms; Antidepressive Agents; Cyclopropanes; Depressive Disorder, Major; Drug Synergism; Female; Humans; Lithium; Male; Milnacipran; Selective Serotonin Reuptake Inhibitors

2004
Ziprasidone-induced galactorrhea: a case report.
    Neuro endocrinology letters, 2005, Volume: 26, Issue:1

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Clonazepam; Depressive Disorder, Major; Female; Galactorrhea; Humans; Lithium; Piperazines; Prolactin; Recurrence; Thiazoles

2005
Severe diurnal somnolence induced by fluvoxamine-lithium combination.
    Pharmacopsychiatry, 2005, Volume: 38, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Disorders of Excessive Somnolence; Drug Therapy, Combination; Fluvoxamine; Humans; Lithium; Male

2005
Lithium and ECT--concurrent use still demands attention: three case reports.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2005, Volume: 6, Issue:2

    Topics: Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Blood-Brain Barrier; Combined Modality Therapy; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Middle Aged

2005
Exacerbation of migraine attacks during treatment with the selective serotonin reuptake inhibitor sertraline. A case report.
    Pharmacopsychiatry, 2005, Volume: 38, Issue:6

    Topics: Adrenergic beta-Antagonists; Antimanic Agents; Depressive Disorder, Major; Female; Humans; Lithium; Metoprolol; Middle Aged; Migraine Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline

2005
[Major depressive disorder in personality disorder].
    L'Encephale, 2005, Volume: 31 Pt 2

    Topics: Adult; Antimanic Agents; Depressive Disorder, Major; Female; Humans; Lithium; Personality Disorders; Severity of Illness Index

2005
Psychoactive drugs and the frail elderly patient.
    American family physician, 1984, Volume: 30, Issue:4

    Topics: Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiety Disorders; Delirium; Depressive Disorder; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Electroconvulsive Therapy; Humans; Lithium; Mood Disorders; Psychotherapy; Psychotropic Drugs; Sleep Wake Disorders

1984
[Various aspects and problems of depression in the aged].
    La Clinica terapeutica, 1984, Feb-15, Volume: 108, Issue:3

    Topics: Aged; Aging; Antidepressive Agents, Tricyclic; Brain; Depressive Disorder, Major; Heart; Humans; Lithium; Organ Size

1984
[Differential phenomenology of depressive states (author's transl)].
    Der Nervenarzt, 1980, Volume: 51, Issue:2

    Topics: Adult; Bipolar Disorder; Depressive Disorder; Depressive Disorder, Major; Epilepsy; Female; Humans; Lithium; Male; Middle Aged

1980
Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression.
    Journal of affective disorders, 2001, Volume: 64, Issue:2-3

    Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Antimanic Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Forecasting; Humans; Lithium; Male; Middle Aged; Retrospective Studies

2001
Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium.
    Brain research bulletin, 2001, Jul-15, Volume: 55, Issue:5

    Topics: Adenylyl Cyclases; Antidepressive Agents; Archives; Bipolar Disorder; Calcium-Calmodulin-Dependent Protein Kinases; Cerebral Cortex; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Depressive Disorder, Major; GTP-Binding Proteins; Humans; Immunoblotting; Lithium; Neurons; Signal Transduction; Tissue Banks

2001
Cyclic AMP levels in cerebrospinal fluid in manic-melancholic patients.
    Neuropsychobiology, 1976, Volume: 2, Issue:4

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Bipolar Disorder; Cyclic AMP; Depression; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Tranquilizing Agents

1976
Paranoid symptoms in patients on a general hospital psychiatric unit. Implications for diagnosis and treatment.
    Archives of general psychiatry, 1978, Volume: 35, Issue:3

    Topics: Adult; Affective Disorders, Psychotic; Antidepressive Agents; Bipolar Disorder; Delusions; Depressive Disorder, Major; Diagnosis, Differential; Diagnostic Errors; Female; Hospitals, General; Humans; Lithium; Male; Middle Aged; Neurocognitive Disorders; Paranoid Behavior; Paranoid Disorders; Psychiatric Department, Hospital; Psychotherapy; Schizophrenia, Paranoid

1978
[Treatment of drug-resistant depressive states with lithium gluconate].
    Annales medico-psychologiques, 1977, Volume: 1, Issue:3

    Topics: Adjustment Disorders; Aged; Bipolar Disorder; Depression; Depressive Disorder, Major; Female; Humans; Lithium; Male; Middle Aged

1977
Lithium toxicity.
    Lancet (London, England), 1970, Feb-21, Volume: 1, Issue:7643

    Topics: Aged; Depression; Depressive Disorder, Major; Female; Humans; Lithium

1970
Clinical effects of lithium carbonate on depression.
    Folia psychiatrica et neurologica japonica, 1973, Volume: 27, Issue:3

    Topics: Adolescent; Adult; Affective Symptoms; Bipolar Disorder; Carbonates; Depression; Depressive Disorder, Major; Female; Humans; Lithium; Male; Middle Aged

1973
Effectiveness of lithium carbonate in the prevention of manic and depressive episodes.
    The Medical clinics of North America, 1972, Volume: 56, Issue:3

    Topics: Adult; Bipolar Disorder; Carbonates; Depressive Disorder, Major; Female; Humans; Hypothyroidism; Lithium; Male; Middle Aged; Recurrence; Schizophrenia; Thyroid Gland; Thyroid Hormones

1972
[Lithium in depressive conditions. A trial in 150 cases during 18 months].
    La Nouvelle presse medicale, 1972, Jun-17, Volume: 1, Issue:25

    Topics: Adjustment Disorders; Adult; Age Factors; Aged; Bipolar Disorder; Depression; Depressive Disorder, Major; Drug Tolerance; Female; Gluconates; Humans; Lithium; Male; Middle Aged; Sodium Chloride

1972
[Recurrence of psychoses in preventive lithium therapy].
    Activitas nervosa superior, 1970, Jan-12, Volume: 12, Issue:1

    Topics: Bipolar Disorder; Chronic Disease; Depression; Depressive Disorder, Major; Humans; Lithium; Psychotic Disorders; Schizophrenia; Time Factors

1970
[Prophylactic administration of lithium carbonate in affective psychoses].
    Ceskoslovenska psychiatrie, 1971, Volume: 67, Issue:2

    Topics: Adult; Age Factors; Aged; Bipolar Disorder; Depressive Disorder, Major; Female; Hospitalization; Humans; Lithium; Male; Middle Aged; Time Factors

1971